BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 30038048)

  • 1. Inhibition of the Protein Phosphatase CppA Alters Development of Chlamydia trachomatis.
    Claywell JE; Matschke LM; Plunkett KN; Fisher DJ
    J Bacteriol; 2018 Oct; 200(19):. PubMed ID: 30038048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTL0511 from Chlamydia trachomatis Is a Type 2C Protein Phosphatase with Broad Substrate Specificity.
    Claywell JE; Fisher DJ
    J Bacteriol; 2016 Jul; 198(13):1827-1836. PubMed ID: 27114464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Active Metabolism on Chlamydia trachomatis Elementary Body Transcript Profile and Infectivity.
    Grieshaber S; Grieshaber N; Yang H; Baxter B; Hackstadt T; Omsland A
    J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29735758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ClpX and ClpP2 Orthologs of Chlamydia trachomatis Perform Discrete and Essential Functions in Organism Growth and Development.
    Wood NA; Blocker AM; Seleem MA; Conda-Sheridan M; Fisher DJ; Ouellette SP
    mBio; 2020 Sep; 11(5):. PubMed ID: 32873765
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmid Negative Regulation of CPAF Expression Is Pgp4 Independent and Restricted to Invasive
    Patton MJ; Chen CY; Yang C; McCorrister S; Grant C; Westmacott G; Yuan XY; Ochoa E; Fariss R; Whitmire WM; Carlson JH; Caldwell HD; McClarty G
    mBio; 2018 Jan; 9(1):. PubMed ID: 29382731
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of the Mitochondrion-Fatty Acid Axis for the Metabolic Reprogramming of Chlamydia trachomatis during Treatment with β-Lactam Antimicrobials.
    Shima K; Kaufhold I; Eder T; Käding N; Schmidt N; Ogunsulire IM; Deenen R; Köhrer K; Friedrich D; Isay SE; Grebien F; Klinger M; Richer BC; Günther UL; Deepe GS; Rattei T; Rupp J
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Protein Phosphorylation on Chlamydial Physiology.
    Claywell JE; Matschke LM; Fisher DJ
    Front Cell Infect Microbiol; 2016; 6():197. PubMed ID: 28066729
    [No Abstract]   [Full Text] [Related]  

  • 8. Initial Characterization of the Two ClpP Paralogs of
    Wood NA; Chung KY; Blocker AM; Rodrigues de Almeida N; Conda-Sheridan M; Fisher DJ; Ouellette SP
    J Bacteriol; 2019 Jan; 201(2):. PubMed ID: 30396899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Repressor Function of the
    Zhang Q; Rosario CJ; Sheehan LM; Rizvi SM; Brothwell JA; He C; Tan M
    J Bacteriol; 2020 Mar; 202(8):. PubMed ID: 31988079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular biology and diagnostics of Chlamydia trachomatis.
    Birkelund S
    Dan Med Bull; 1992 Aug; 39(4):304-20. PubMed ID: 1526183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia trachomatis Plasmid Gene Protein 3 Is Essential for the Establishment of Persistent Infection and Associated Immunopathology.
    Yang C; Kari L; Lei L; Carlson JH; Ma L; Couch CE; Whitmire WM; Bock K; Moore I; Bonner C; McClarty G; Caldwell HD
    mBio; 2020 Aug; 11(4):. PubMed ID: 32817110
    [No Abstract]   [Full Text] [Related]  

  • 12. The Periplasmic Tail-Specific Protease, Tsp, Is Essential for Secondary Differentiation in
    Swoboda AR; Wood NA; Saery EA; Fisher DJ; Ouellette SP
    J Bacteriol; 2023 May; 205(5):e0009923. PubMed ID: 37092988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrogating Genes That Mediate Chlamydia trachomatis Survival in Cell Culture Using Conditional Mutants and Recombination.
    Brothwell JA; Muramatsu MK; Toh E; Rockey DD; Putman TE; Barta ML; Hefty PS; Suchland RJ; Nelson DE
    J Bacteriol; 2016 Aug; 198(15):2131-9. PubMed ID: 27246568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosmidomycin, an inhibitor of isoprenoid synthesis, induces persistence in Chlamydia by inhibiting peptidoglycan assembly.
    Slade JA; Brockett M; Singh R; Liechti GW; Maurelli AT
    PLoS Pathog; 2019 Oct; 15(10):e1008078. PubMed ID: 31622442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance.
    McCoy AJ; Sandlin RC; Maurelli AT
    J Bacteriol; 2003 Feb; 185(4):1218-28. PubMed ID: 12562791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homologues of the Chlamydia trachomatis and Chlamydia muridarum Inclusion Membrane Protein IncS Are Interchangeable for Early Development but Not for Inclusion Stability in the Late Developmental Cycle.
    Cortina ME; Derré I
    mSphere; 2023 Apr; 8(2):e0000323. PubMed ID: 36853051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel protease inhibitor causes inclusion vacuole reduction and disrupts the intracellular growth of Chlamydia trachomatis.
    Zhou Y; Lu X; Huang D; Lu Y; Zhang H; Zhang L; Yu P; Wang F; Wang Y
    Biochem Biophys Res Commun; 2019 Aug; 516(1):157-162. PubMed ID: 31202460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion Membrane Growth and Composition Are Altered by Overexpression of Specific Inclusion Membrane Proteins in Chlamydia trachomatis L2.
    Olson-Wood MG; Jorgenson LM; Ouellette SP; Rucks EA
    Infect Immun; 2021 Jun; 89(7):e0009421. PubMed ID: 33875478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism.
    Fields KA; Hackstadt T
    Mol Microbiol; 2000 Dec; 38(5):1048-60. PubMed ID: 11123678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Inactivation of
    Shaw JH; Key CE; Snider TA; Sah P; Shaw EI; Fisher DJ; Lutter EI
    Front Cell Infect Microbiol; 2018; 8():415. PubMed ID: 30555802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.